Salvage treatment for refractory or relapsed acute myeloid leukemia: a 10-year single-center experience (2020)
- Authors:
- USP affiliated authors: VELLOSO, ELVIRA DEOLINDA RODRIGUES PEREIRA - FM ; ROCHA, VANDERSON GERALDO - FM ; REGO, Eduardo M. - FM
- Unidade: FM
- DOI: 10.6061/clinics/2020/e1566
- Subjects: ANTINEOPLÁSICOS; LEUCEMIA; MEIA IDADE; ESTUDOS RETROSPECTIVOS; TAXA DE SOBREVIVÊNCIA; RESULTADO DE TRATAMENTO
- Language: Inglês
- Imprenta:
- Source:
- Este periódico é de acesso aberto
- Este artigo NÃO é de acesso aberto
-
ABNT
SILVA, Wellington Fernandes da et al. Salvage treatment for refractory or relapsed acute myeloid leukemia: a 10-year single-center experience. Clinics, v. 75, 2020Tradução . . Disponível em: https://doi.org/10.6061/clinics/2020/e1566. Acesso em: 12 fev. 2026. -
APA
Silva, W. F. da, Rosa, L. I. da, Seguro, F. S., Silveira, D. R. A., Bendit, I., Buccheri, V., et al. (2020). Salvage treatment for refractory or relapsed acute myeloid leukemia: a 10-year single-center experience. Clinics, 75. doi:10.6061/clinics/2020/e1566 -
NLM
Silva WF da, Rosa LI da, Seguro FS, Silveira DRA, Bendit I, Buccheri V, Velloso EDRP, Rocha VG, Rego EM. Salvage treatment for refractory or relapsed acute myeloid leukemia: a 10-year single-center experience [Internet]. Clinics. 2020 ; 75[citado 2026 fev. 12 ] Available from: https://doi.org/10.6061/clinics/2020/e1566 -
Vancouver
Silva WF da, Rosa LI da, Seguro FS, Silveira DRA, Bendit I, Buccheri V, Velloso EDRP, Rocha VG, Rego EM. Salvage treatment for refractory or relapsed acute myeloid leukemia: a 10-year single-center experience [Internet]. Clinics. 2020 ; 75[citado 2026 fev. 12 ] Available from: https://doi.org/10.6061/clinics/2020/e1566 - Deletion of RUNX1 exons 1 and 2 associated with familial platelet disorder with propensity to acute myeloid leukemia
- Treating Adult Acute Lymphoblastic Leukemia in Brazil-Increased Early Mortality Using a German Multicenter Acute Lymphoblastic Leukemia-based regimen
- Comparison of characteristics and laboratory tests of COVID-19 hematological patients from France and Brazil during the pre-vaccination period: identification of prognostic profiles for survival
- Outcomes of subsequent neoplasms after umbilical cord blood transplantation in Europe
- Outcomes after Haploidentical Stem Cell Transplantation with Post-Transplantation Cyclophosphamide in Patients with Primary Immunodeficiency Diseases
- A novel mutation in RHAG causing Rh-null phenotype in Colombia. [Editorial]
- Comparative analysis of the variability of the human leukocyte antigen peptide-binding pockets in patients with acute leukaemia
- Cord blood transplantation for adult mature lymphoid neoplasms in Europe and Japan
- Autologous, allogeneic hematopoietic cell transplantation and CAR-T/NK therapy: what is their real importance in PTCL?
- Long-term clinical outcomes in a cohort of patients with solitary plasmacytoma treated in the modern era
Informações sobre o DOI: 10.6061/clinics/2020/e1566 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
